HIF1A and liver cancer: In order to further clarify the interaction mechanism between Bclaf1 and HIF-1α, we use CRISPR/Cas9 technology to knock out Bclaf1, and detect the expression of HIF-1α in liver cancer cells after knocking out Bclaf1 under hypoxia.